SAN JOSE, Calif., June 23, 2025--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial ...

Participants had a median age of 70 years. Women constituted 54.9% of the EVT group and 47.3% of controls. At baseline, NIH Stroke Scale scores averaged 16.4 and 17.2, respectively.

Cite this: Successful Implementation of the National Institutes of Health Stroke Scale on a Stroke/Neurovascular Unit - Medscape - Sep 01, 2006.

In addition, the severity of stroke was higher when the stroke was paired with COVID-19 exposure compared with those who did not have COVID-19 exposure (NIH Stroke Scale scores: COVID-19, 9.7; no ...

The approval was based on data from the phase 3 THALES trial (N=11,016) that compared treatment with ticagrelor plus aspirin to aspirin alone in preventing new stroke events.

The National Institutes of Health Stroke Scale (NIHSS) is a well-validated, reliable scoring system for use specifically with stroke patients (Goldstein, Bertels, & Davis, 1989; Lyden et al., 1999).